Login / Signup

Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements.

Scott M PearsonJennifer M Trujillo
Published in: Therapeutic advances in endocrinology and metabolism (2018)
Patients who transitioned from Gla-100 to Gla-300 had increased basal insulin requirements between visits, while basal insulin requirements for those transitioned from Gla-100 to insulin degludec were not significantly different.
Keyphrases
  • type diabetes
  • glycemic control
  • metabolic syndrome
  • adipose tissue